com.insightguru.giraffe.server.utils.PresentationUtil$PresentationTitle@21c3fe4e
This site requires JavaScript to function properly.
For help enabling JavaScript click here.
Here are some sample widgets you could interact with from this dashboard:
(1) Revenues expected to be slightly ahead of consensus estimates
Trefis estimates MDT's FQ1 2022 revenues to be $7.9 Bil, slightly ahead of the consensus estimate of $7.86 Bil
Estimated Revenues - 2022Q1(E)
Trefis Estimates for Medtronic Revenues:
Expected Change (YoY): 21.4%
The chart to the right highlights trends in Medtronic's Revenues over the last four quarters along with our forecast for FQ1 2022.
Quarterly Revenue Trend
(2) EPS likely to marginally beat consensus estimates
MDT's FQ1 2022 earnings per share (EPS) expected to be $1.35 per Trefis analysis, marginally beating the consensus estimate of $1.32 by 2.3%
Estimated EPS- 2022Q1(E)
Trefis Estimates for Medtronic EPS:
Expected Change (YoY): 275.0%
The chart to the right highlights trends in MDT's EPS over the last four quarters along with our forecast for FQ1 2022.
Quarterly EPS Trend
(3) Stock price estimate 15% higher than current market price
Trefis maintains a fair value of $148 for MDT's stock as opposed to the current market price of roughly $129.
MDT Stock Price
The Trefis Price Estimate for Medtronic stock represents the fair value for the company's stock over a one-year horizon.
Details about the chances of a rise in MDT stock in the near term can be found in a separate interactive dashboard.
The chart to the right highlights trends in MDT's stock price at the end of each of the last four quarters as well as the current stock price.
Stock Price (Quarter End)
#1. Estimating Medtronic's Total Revenues:
Medtronic's Revenues have seen a marginal decrease of -1.4% from around $31 Bil in FY2019 to $30 Bil in FY2021 and we expect it to increase to $33 Bil in FY2022
Total Revenue
A Separate Interactive Dashboard Analysis On Medtronic's Revenues Details How The Company Makes Money.
#2. Deriving Medtronic's Adjusted Net Income:
Medtronic's Adjusted Net Income has decreased from around $6.5 Bil in FY2019 to $6.0 Bil in FY2021 and we expect it to increase to $7.6 Bil in FY2022
This change is likely to be led by higher revenues and improved margins.
A Separate Interactive Dashboard Analysis On Medtronic's Margins Highlights The Company's Various Expenses Components In Detail.
Adjusted Net Income [AxB]
Adjusted Net Income Margin [A]
Total Revenue [B]
#3. Determining Medtronic's Adjusted EPS:
Medtronic's Adjusted EPS has decreased from $4.77 in FY2019 to $4.43 in FY2021 and we expect it to increase to $5.71 in FY2022
The change in EPS can be attributed to an increase in adjusted net income and a lower expected share count due to stock repurchases.
Adjusted EPS [A÷B]
Adjusted Net Income [A]
Shares Outstanding [B]
#4. Estimating Medtronic's Share Price:
Our Price Estimate of $148 For Medtronic's Stock is based on our Detailed Valuation Model, and implies a 26.0x P/E Multiple on expected FY2022 Adjusted EPS of $5.71
Trefis Price Estimate [AxB]
Adjusted EPS [A]
P/E Multiple [B]